Henin Lukinz Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.60 M
as on 12-12-2024
- Paid Up Capital ₹ 1.60 M
as on 12-12-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 Cr
as on 12-12-2024
- Revenue %
(FY 2022)
- Profit 15.24%
(FY 2022)
- Net Worth -10.51%
(FY 2022)
- Total Assets -1.42%
(FY 2022)
About Henin Lukinz Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.60 M and a paid-up capital of Rs 1.60 M.
The company has closed loans amounting to ₹1.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Manish Gupta and Saurabh Gupta serve as directors at the Company.
- CIN/LLPIN
U24232CH2012PTC033845
- Company No.
033845
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationChandigarh, Chandigarh
- Telephone
- Email Address
- Website
- Social Media
What products or services does Henin Lukinz Pharma Private Limited offer?
Henin Lukinz Pharma Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines, Antiparasitic Drug, Gastrointestinal Drugs, Malaria Medicine.
Who are the key members and board of directors at Henin Lukinz Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Gupta  | Director | 06-Jun-2012 | Current |
| Saurabh Gupta | Director | 22-Aug-2019 | Current |
Financial Performance of Henin Lukinz Pharma.
Henin Lukinz Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 15.24% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Henin Lukinz Pharma?
In 2022, Henin Lukinz Pharma had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Lifevision Healthcare And Cosmetics Private LimitedInactive For E-Filing 5 months 3 daysManish Gupta and Saurabh Gupta are mutual person
- Four Pillars Industries Private LimitedActive 1 year 6 months
Manish Gupta and Saurabh Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 26 Feb 2015 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Henin Lukinz Pharma?
Unlock and access historical data on people associated with Henin Lukinz Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Henin Lukinz Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Henin Lukinz Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
